Related Experiment Video
Updated: Aug 31, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors
Qinqin Xu1, Xinyue Lan1,2, Huimin Lin1
1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.
Abstract:
The tumor microenvironment (TME) is a very cunning system that enables tumor cells to escape death post-traditional antitumor treatments through the comprehensive effect of different factors, thereby leading to drug resistance. Deep insights into TME characteristics and tumor resistance encourage the construction of nanomedicines that can remodel the TME against drug resistance. Tremendous interest in combining TME-regulation measurement with traditional tumor treatment to fight multidrug-resistant tumors has been inspired by the increasing understanding of the role of TME reconstruction in improving the antitumor efficiency of drug-resistant tumor therapy. This review focuses on the underlying relationships between specific TME characteristics (such as hypoxia, acidity, immunity, microorganisms, and metabolism) and drug resistance in tumor treatments. The exciting antitumor activities strengthened by TME regulation are also discussed in-depth, providing solutions from the perspective of nanomedicine design. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.
Insights
The tumor microenvironment (TME) drives drug resistance in cancer. Nanomedicines can remodel the TME to overcome this resistance and enhance antitumor efficacy.
Area of Science:
- Oncology
- Nanotechnology
- Drug Discovery
Background:
- The tumor microenvironment (TME) facilitates tumor cell survival and promotes drug resistance.
- Understanding TME complexity is crucial for developing effective cancer therapies.
Purpose of the Study:
- To review the relationship between TME characteristics and tumor drug resistance.
- To explore nanomedicine strategies for TME remodeling to combat drug resistance.
Main Methods:
- Literature review focusing on TME factors (hypoxia, acidity, immunity, metabolism, microorganisms).
- Analysis of nanomedicine approaches for TME modulation in cancer therapy.
Main Results:
- Specific TME features significantly contribute to multidrug resistance in tumors.
- TME remodeling strategies, particularly via nanomedicine, show promise in enhancing antitumor activity.
Conclusions:
- Targeting the TME is a viable strategy to overcome cancer drug resistance.
- Nanomedicine offers innovative solutions for TME-based cancer treatment.
Related Concept Videos
The Tumor Microenvironment
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Drugs that Stabilize Microtubules

